-transparent.png){kind=logo}
In this report, the temporal sequence of myopathology during a clofibrate-induced muscular syndrome and its recovery in rats is described using histopathologic, histochemical and electron microscopic technics. Two stages of myopathology are described: an early stage characterized by myopathic features, and a later stage characterized by neurogenic features. Although muscle histology returns to normal after 1 week of discontinuing the drug, electron microscopic abnormalities persist through the second week. It is proposed that clofibrate, in addition to its myotoxic effect, may be neurotoxic.
Related Publications
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
April 1983,
Acta neurologica Scandinavica,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
October 1978,
Journal of neurology,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
June 2012,
European journal of internal medicine,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
June 1996,
Revista de saude publica,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
December 2016,
International journal of immunopathology and pharmacology,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
November 2020,
The Veterinary clinics of North America. Food animal practice,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
January 2020,
Frontiers in genetics,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
January 2011,
Journal of biomedicine & biotechnology,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
December 1979,
Biochemical pharmacology,
A K Afifi, and
G A Hajj, and
S Saad, and
A Tekian, and
R A Bergman, and
N B Bahuth, and
N Abourizk
January 1982,
Oncology,
